Videos |
|
xv | |
Foreword |
|
xvi | |
Preface |
|
xviii | |
Contributors |
|
xix | |
|
Section I Some Characteristics and Theories |
|
|
|
|
3 | (13) |
|
|
|
|
|
3 | (1) |
|
1.2 Common Characteristics: Definitions of Stuttering, Speech Disfluency Types and Stuttered and Nonstuttered Disfluencies |
|
|
3 | (1) |
|
|
3 | (1) |
|
1.2.2 Speech Disfluency Types |
|
|
3 | (1) |
|
1.2.3 Stuttered and Nonstuttered Disfluencies |
|
|
3 | (1) |
|
1.3 Common Characteristics: Measures of Stuttering and Associated Variables |
|
|
4 | (1) |
|
1.3.1 Stuttering Frequency |
|
|
4 | (1) |
|
1.3.2 Stuttering Severity |
|
|
4 | (1) |
|
1.3.3 Associated (Non) Speech Behaviors |
|
|
4 | (1) |
|
1.3.4 Speaking Rate and Speech Naturalness |
|
|
5 | (1) |
|
1.4 Common Characteristics: Variability (General Aspects) |
|
|
5 | (2) |
|
|
5 | (1) |
|
1.4.2 Non-normally Distributed |
|
|
6 | (1) |
|
1.5 Common Characteristics: Variability (Specific Aspects) |
|
|
7 | (2) |
|
|
7 | (1) |
|
1.5.2 After the Effects of Adaptation Have Dissipated |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
1.6 Other Common Characteristics: Age at Onset, Gender, Persistence, and Recovery from Stuttering |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
1.6.3 Stuttering Persistence and Recovery |
|
|
10 | (1) |
|
1.7 Common Characteristics: Behaviors and Conditions that Decrease Stuttering |
|
|
10 | (3) |
|
1.7.1 Behaviors associated with Decreases in Stuttering |
|
|
10 | (1) |
|
1.7.2 Conditions Associated with Decreases in Suttering |
|
|
11 | (2) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
13 | (3) |
|
|
14 | (2) |
|
2 Some 20th- and 21st-Century Theories of Stuttering: A Brief Overview |
|
|
16 | (21) |
|
|
|
|
|
16 | (1) |
|
2.2 Humoral System of Medicine |
|
|
16 | (1) |
|
2.3 The Beginnings: Shifting from Humoral to Scientific Approaches |
|
|
17 | (1) |
|
2.4 The 18th and 19th Centuries: Establishment of the Scientific Method |
|
|
18 | (1) |
|
2.5 The 19th and 20th Century: Physiological and Psychological Theories |
|
|
18 | (1) |
|
2.6 The Early to Mid-20th Century: Physiological and Psychosocial Theories |
|
|
19 | (2) |
|
2.6.1 Nature Perspectives |
|
|
19 | (1) |
|
2.6.2 Nurture Perspective |
|
|
20 | (1) |
|
2.7 The Late 20th Century: Learning and Multifactorial Theories |
|
|
21 | (2) |
|
2.7.1 Nurture Perspectives |
|
|
21 | (2) |
|
2.7.2 Nature and Nurture Interaction Perspectives |
|
|
23 | (1) |
|
2.8 Late 20th to Early 21st Century: Prominent Contemporary Theories |
|
|
23 | (4) |
|
2.8.1 Speech-Language Planning Theories |
|
|
23 | (1) |
|
2.8.2 Multifactorial Theories |
|
|
24 | (2) |
|
2.8.3 Computational/Neurocomputational Models |
|
|
26 | (1) |
|
2.9 Further Considerations |
|
|
27 | (3) |
|
2.9.1 Theories of Stuttering Etiology |
|
|
27 | (1) |
|
2.9.2 Antecedents to versus Consequences of Stuttering |
|
|
28 | (1) |
|
2.9.3 The Diagnosis versus the Behavior of Stuttering |
|
|
28 | (1) |
|
2.9.4 Nature, Nurture, and Their Interaction |
|
|
29 | (1) |
|
2.9.5 Different Measurements, Different Results |
|
|
30 | (1) |
|
2.9.6 A Varying Effect, an Unvarying Cause |
|
|
30 | (1) |
|
|
30 | (1) |
|
2.10.1 Recipes/Ingredients |
|
|
30 | (1) |
|
2.10.2 Divergent Approaches to Same Topic |
|
|
31 | (1) |
|
2.10.3 The Only Certainty is That Nothing is Certain |
|
|
31 | (1) |
|
2.10.4 Facts Are the Foundation |
|
|
31 | (1) |
|
|
31 | (6) |
|
|
32 | (5) |
|
Section II Processes Associated with Stuttering |
|
|
|
|
37 | (15) |
|
|
|
|
37 | (1) |
|
3.1.1 Heritability of Stuttering |
|
|
37 | (1) |
|
3.2 Introduction to Basic Genetics |
|
|
38 | (2) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
40 | (1) |
|
3.3.1 Chromosomal Abnormalities |
|
|
40 | (1) |
|
3.3.2 Another Variation in the Human Genome: Single Nucleotide Polymorphism (SNP) |
|
|
40 | (1) |
|
3.4 Strategies for Measuring Genetic Variation |
|
|
41 | (1) |
|
3.4.1 Epigenetic Factors in the Expression of DNA |
|
|
41 | (1) |
|
3.5 Transmission Models of Inheritance |
|
|
41 | (1) |
|
3.5.1 Autosomal Dominant Inheritance |
|
|
42 | (1) |
|
3.5.2 Autosomal Recessive Inheritance |
|
|
42 | (1) |
|
3.5.3 Approaches to Mapping Disease Genes: Linkage Analysis |
|
|
42 | (1) |
|
3.5.4 Association Studies |
|
|
42 | (1) |
|
3.6 Genetic Studies of Stuttering |
|
|
42 | (3) |
|
3.6.1 Stuttering Risk: GNPTAB and Lysosomal Transport Genes |
|
|
44 | (1) |
|
3.6.2 DRD2: A Potential Role for Dopamine in Stuttering Risk |
|
|
44 | (1) |
|
3.6.3 AP4E1: Intercellular Trafficking and Stuttering Risk |
|
|
44 | (1) |
|
3.6.4 Hormone Regulation May Explain Biological Sex Differences in Stuttering Risk |
|
|
44 | (1) |
|
3.6.5 Introducing Genetic Mutations into Animal Models of Stuttering |
|
|
45 | (1) |
|
3.7 Sources of Large-Scale Genetic Data from People Who Stutter |
|
|
45 | (2) |
|
3.7.1 The International Stuttering Project |
|
|
45 | (1) |
|
|
45 | (1) |
|
3.7.3 Phenome Wide Association Studies (PheWAS) |
|
|
45 | (1) |
|
3.7.4 Additional Considerations: Analyzing Comorbidities Associated with Stuttering |
|
|
46 | (1) |
|
3.7.5 Summary of Findings from Genetic Studies in Stuttering |
|
|
47 | (1) |
|
3.8 Applying Research Findings to Models and Characteristics of Stuttering |
|
|
47 | (1) |
|
3.8.1 Modeling Polygenic Risk of Stuttering |
|
|
47 | (1) |
|
3.8.2 Correlations between Stuttering Risk and Related Traits |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (3) |
|
|
50 | (2) |
|
4 Speech, Language, and Cognitive Processes |
|
|
52 | (15) |
|
|
|
|
|
52 | (1) |
|
4.2 Linguistic Constraints on Stuttering |
|
|
53 | (1) |
|
4.3 Speech and Language Abilities and Stuttering |
|
|
54 | (3) |
|
4.3.1 Articulation and Phonology |
|
|
55 | (1) |
|
4.3.2 Vocabulary and Morphosyntax |
|
|
55 | (1) |
|
|
56 | (1) |
|
4.4 Cognitive Processes and Stuttering |
|
|
57 | (2) |
|
|
57 | (1) |
|
|
58 | (1) |
|
|
59 | (1) |
|
4.5 Implications for Theory and Clinical Practice |
|
|
59 | (3) |
|
|
59 | (2) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
64 | (3) |
|
|
64 | (3) |
|
5 Neural and Physiological Processes |
|
|
67 | (11) |
|
|
|
|
|
67 | (1) |
|
5.2 Level 1: Perceptual Disfluency |
|
|
68 | (1) |
|
5.3 Level 2: Articulator Laryngeal, and Respiratory Dynamics |
|
|
68 | (1) |
|
5.4 Level 3: Neuromuscular Activation |
|
|
69 | (1) |
|
5.5 Level 4: Electrocortical Activation |
|
|
69 | (2) |
|
5.6 Level 5: Brain Regions and Networks |
|
|
71 | (2) |
|
5.6.1 Structural Differences in Brain Regions and Networks of PWS |
|
|
72 | (1) |
|
5.6.2 Functional Differences in Brain Regions and Networks of PWS |
|
|
72 | (1) |
|
|
73 | (2) |
|
5.7.1 Theoretical Implications |
|
|
73 | (1) |
|
5.7.2 Treatment Implications and Future Directions |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (3) |
|
|
76 | (2) |
|
6 Temperamental and Emotional Processes |
|
|
78 | (17) |
|
|
|
|
6.1 Brief Overview of Temperament and Emotional Processes |
|
|
78 | (5) |
|
|
78 | (2) |
|
6.1.2 Measurement of Temperament |
|
|
80 | (1) |
|
|
80 | (3) |
|
6.1.4 Role of Temperament and Emotion |
|
|
83 | (1) |
|
6.2 The Association between Temperamental and Emotional Processes and Developmental Stuttering |
|
|
83 | (3) |
|
6.2.1 Differences between People Who Stutter and People Who Do Not Stutter |
|
|
84 | (1) |
|
6.2.2 Association with Stuttering Frequency and Severity |
|
|
84 | (1) |
|
6.2.3 Summary of Empirical Evidence and Takeaways |
|
|
84 | (2) |
|
6.3 Theoretical and Clinical Implications |
|
|
86 | (2) |
|
6.3.1 Directionality of the Effect |
|
|
86 | (1) |
|
6.3.2 Theoretical Implications |
|
|
86 | (1) |
|
6.3.3 Diagnostic Implications |
|
|
86 | (1) |
|
6.3.4 Treatment Implications |
|
|
87 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (7) |
|
|
89 | (6) |
|
Section III Diagnosis of Stuttering |
|
|
|
|
95 | (24) |
|
|
|
|
|
95 | (1) |
|
7.2 Setting the Stage for Assessing Preschoolers Who Stutter |
|
|
95 | (1) |
|
7.2.1 Multidimensional Assessment of a Multifactorial Disorder |
|
|
95 | (1) |
|
7.3 Preschool Stuttering Assessment: Look, Listen, and Learn |
|
|
95 | (13) |
|
7.3.1 Considering "Risk Factors" for Persistent Stuttering |
|
|
95 | (2) |
|
7.3.2 Assessing the Child |
|
|
97 | (8) |
|
7.3.3 Compiling and Synthesizing Results and Making Recommendations |
|
|
105 | (3) |
|
|
108 | (1) |
|
|
108 | (2) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (9) |
|
|
110 | (1) |
|
|
111 | (3) |
|
|
114 | (3) |
|
|
117 | (2) |
|
|
119 | (17) |
|
|
|
|
119 | (1) |
|
8.2 A Framework for Assessing Stuttering In School-Aged Children |
|
|
119 | (14) |
|
8.2.1 School-Age Children and Stuttering |
|
|
119 | (2) |
|
8.2.2 An Assessment Protocol for School-Aged Children Who Stutter |
|
|
121 | (12) |
|
|
133 | (1) |
|
|
133 | (1) |
|
|
133 | (1) |
|
8.3.3 Clinical Application Questions for the Case Study |
|
|
133 | (1) |
|
|
133 | (1) |
|
|
134 | (2) |
|
|
134 | (2) |
|
|
136 | (17) |
|
|
|
|
136 | (1) |
|
|
136 | (1) |
|
9.1.2 Client Expectations: A Word about Controlled Speech versus Spontaneous Fluency |
|
|
136 | (1) |
|
9.1.3 Impact of Stuttering and What Needs to Change |
|
|
137 | (1) |
|
9.2 A Clinical Definition of Stuttering |
|
|
137 | (1) |
|
9.3 Anticipation: Stuttering Below the Surface |
|
|
137 | (2) |
|
9.4 Measuring the Unobservable and Observable: A Framework for Stuttering Assessment |
|
|
139 | (2) |
|
9.4.1 Impact of Stuttering |
|
|
139 | (1) |
|
9.4.2 Variability Not Frequency of Stuttering |
|
|
140 | (1) |
|
9.4.3 Reframing Overt and Covert Aspects of Stuttering: Technical and Adaptive Challenges |
|
|
140 | (1) |
|
9.5 The Assessment Process |
|
|
141 | (4) |
|
|
141 | (1) |
|
9.5.2 Diagnostic Interview |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (2) |
|
|
147 | (1) |
|
|
147 | (6) |
|
|
147 | (2) |
|
Appendix 9.1 Sample Case History Form for Adult Stutterers |
|
|
149 | (4) |
|
Section IV Treatment of Stuttering |
|
|
|
10 Preschool-Age Children |
|
|
153 | (21) |
|
|
|
|
|
153 | (1) |
|
10.2 Therapy Approaches for Preschool Children Who Stutter |
|
|
154 | (14) |
|
10.2.1 Palin Parent-Child Interaction Therapy |
|
|
154 | (5) |
|
10.2.2 The Lidcombe Program |
|
|
159 | (5) |
|
10.2.3 Restart-Demands and Capacities Model Based Treatment |
|
|
164 | (4) |
|
|
168 | (1) |
|
10.4 Conclusions and Future Directions |
|
|
169 | (5) |
|
|
169 | (2) |
|
|
171 | (1) |
|
|
172 | (2) |
|
|
174 | (18) |
|
|
|
|
|
|
174 | (1) |
|
11.2 The Importance of Assessment |
|
|
174 | (1) |
|
11.3 General Considerations for Working with School-Age Children |
|
|
175 | (2) |
|
11.3.1 School-Age Children Who Stutter Are Still Growing |
|
|
175 | (1) |
|
11.3.2 Stuttering Affects School-Age Children Differently from Preschool Children |
|
|
176 | (1) |
|
11.3.3 School-Age Children Are Not Adolescents or Adults |
|
|
176 | (1) |
|
11.3.4 Stuttering Also Affects School-Age Children's Caregivers Differently |
|
|
176 | (1) |
|
11.4 Comprehensive Treatment for School-Age Children Who Stutter |
|
|
177 | (4) |
|
11.4.1 A Framework for Understanding Stuttering |
|
|
177 | (1) |
|
11.4.2 Selecting Appropriate Treatment Goals |
|
|
178 | (1) |
|
11.4.3 Focusing on Communication Rather than Speech Fluency as a Primary Outcome |
|
|
179 | (1) |
|
11.4.4 The Importance of Practice-Based Evidence |
|
|
180 | (1) |
|
11.5 Sample Treatment Goals, Procedures, and Activities for School-Age Children Who Stutter |
|
|
181 | (7) |
|
11.5.1 Sample Goals, Procedures, and Activities: Stuttering Impairment |
|
|
181 | (1) |
|
11.5.2 Sample Goals, Procedures, and Activities: Child's Reactions to Stuttering |
|
|
182 | (2) |
|
11.5.3 Sample Goals, Procedures, and Activities: Environment's Reactions to Stuttering |
|
|
184 | (2) |
|
11.5.4 Sample Goals, Procedures, and Activities: Activity Limitations and Participation Restrictions |
|
|
186 | (2) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
189 | (3) |
|
|
189 | (3) |
|
12 Adolescents and Adults |
|
|
192 | (23) |
|
|
|
|
|
192 | (1) |
|
12.2 What Needs To Be Changed about Stuttering and Who Decides? |
|
|
192 | (1) |
|
12.3 What Contributes to Treatment Outcomes? |
|
|
193 | (2) |
|
12.3.1 The Common Factors |
|
|
193 | (1) |
|
12.3.2 Spotlight on the Client's Contribution to Therapy Outcomes: Stages of Change |
|
|
194 | (1) |
|
12.4 Getting Started: A Stage-Based Framework for Therapy Planning |
|
|
195 | (5) |
|
12.4.1 Creating the Therapy Plan: Deciding What is Helpful |
|
|
195 | (4) |
|
12.4.2 Implementing the Therapy Plan: Learning the Things that Help |
|
|
199 | (1) |
|
12.5 Selecting Therapy Approaches: Learn to Speak More Fluently or Stutter More Easily |
|
|
200 | (4) |
|
12.5.1 Normal Talking Process |
|
|
200 | (3) |
|
12.5.2 Speak More Fluently |
|
|
203 | (1) |
|
12.5.3 Stutter More Easily |
|
|
203 | (1) |
|
|
204 | (1) |
|
12.6 Selecting Therapy Approaches: Changing Thoughts and Feelings |
|
|
204 | (2) |
|
12.6.1 Listening and Valuing |
|
|
205 | (1) |
|
12.6.2 Cognitive Behavioral Therapy |
|
|
205 | (1) |
|
|
206 | (1) |
|
12.7.1 Acceptance and Commitment Therapy |
|
|
206 | (1) |
|
12.7.2 Solution-Focused Brief Therapy |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
12.7.5 Self-Help and Support Organizations |
|
|
207 | (1) |
|
12.8 Selecting Therapy Approaches: Approaching Talking without Avoiding |
|
|
207 | (1) |
|
12.8.1 Avoidance Reduction Therapy for Stuttering |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
208 | (1) |
|
|
208 | (1) |
|
12.9 Putting It All Together: Two Cases |
|
|
208 | (7) |
|
|
208 | (2) |
|
Appendix 12.1 Case Study: Teen |
|
|
210 | (1) |
|
Appendix 12.2 Case Study: Adult |
|
|
210 | (1) |
|
|
211 | (4) |
|
Section V Additional Treatment Considerations |
|
|
|
13 Language and Phonological Considerations |
|
|
215 | (12) |
|
|
|
|
|
215 | (1) |
|
13.2 Intervention Principles |
|
|
216 | (1) |
|
13.3 Diagnostic Considerations |
|
|
216 | (1) |
|
13.3.1 A Thorough Evaluation |
|
|
216 | (1) |
|
13.3.2 Differential Diagnosis |
|
|
216 | (1) |
|
13.3.3 Profiles of "Atypical" Disfluency |
|
|
217 | (1) |
|
|
217 | (8) |
|
13.4.1 Principles of Evidence-Based Practice and Practice-Based Evidence |
|
|
217 | (1) |
|
13.4.2 Monitoring Outcomes |
|
|
218 | (1) |
|
13.4.3 Therapeutic Approaches |
|
|
219 | (3) |
|
13.4.4 Linguistic Context |
|
|
222 | (1) |
|
13.4.5 Treating Concomitant Stuttering and Phonology |
|
|
222 | (2) |
|
13.4.6 Treating Concomitant Stuttering and Language |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (2) |
|
14 Bilingual and Multicultural Considerations |
|
|
227 | (9) |
|
|
|
|
|
227 | (1) |
|
|
227 | (1) |
|
14.2 Speech, Language, and Fluency in Bilingual Speakers |
|
|
228 | (1) |
|
14.3 Challenges In Identifying Stuttering in Bilingual Speakers |
|
|
228 | (2) |
|
14.3.1 Use of Monolingual Guidelines for Stuttering Assessment |
|
|
228 | (1) |
|
14.3.2 Speech Disfluencies Produced by Bilingual Children Who Do Not Stutter |
|
|
229 | (1) |
|
14.3.3 Misperception of Bilingualism as a Risk Factor for Stuttering |
|
|
229 | (1) |
|
14.3.4 Inconsistency in the Description of Bilingualism |
|
|
230 | (1) |
|
14.3.5 Assumption That Stuttering is Related to Language Dominance |
|
|
230 | (1) |
|
14.4 Culturally and Linguistically Sensitive Assessment of Stuttering |
|
|
230 | (2) |
|
14.4.1 Formal Assessment of Stuttering |
|
|
231 | (1) |
|
14.4.2 Informal Assessment of Stuttering |
|
|
231 | (1) |
|
14.5 Additional Cultural Considerations |
|
|
232 | (1) |
|
|
232 | (1) |
|
14.5.2 Conversational Style |
|
|
232 | (1) |
|
14.5.3 Views on the Cause of Stuttering |
|
|
232 | (1) |
|
14.6 Considerations for Intervention |
|
|
233 | (1) |
|
|
234 | (2) |
|
|
234 | (2) |
|
15 Pharmacological Considerations |
|
|
236 | (23) |
|
|
|
|
|
236 | (1) |
|
15.2 Stuttering and the Dopamine Hypothesis |
|
|
237 | (2) |
|
15.3 Stuttering and the "Two-Loop" Hypothesis of Speech Output |
|
|
239 | (1) |
|
15.4 Background Pertaining to Pharmacotherapy for Stuttering |
|
|
240 | (2) |
|
15.4.1 Neuropharmacology Impact on Neurotransmitters: Reuptake |
|
|
240 | (1) |
|
15.4.2 Limiting or Controlling the Placebo Effect |
|
|
241 | (1) |
|
15.4.3 Four Phases of Clinical Trials and the Example of Pagoclone |
|
|
241 | (1) |
|
15.5 Medications for Stuttering: A Historical Perspective |
|
|
242 | (6) |
|
15.6 The Effect of Medications prescribed for Other Conditions on Stuttering |
|
|
248 | (3) |
|
15.6.1 Parkinsonism versus Parkinson's Disease and "Stuttering" |
|
|
248 | (1) |
|
15.6.2 Schizophrenia, Bipolar Disorder, Major Depressive Disorder, and Stuttering |
|
|
248 | (1) |
|
15.6.3 Anxiety Disorders and Stuttering |
|
|
249 | (1) |
|
15.6.4 Tourette's Syndrome and Stuttering |
|
|
250 | (1) |
|
15.6.5 Attention Deficit Hyperactivity Disorder and stuttering |
|
|
250 | (1) |
|
15.6.6 Autoimmune conditions and stuttering |
|
|
250 | (1) |
|
15.7 Recreational Drugs and Self-medicating Behaviors and Stuttering |
|
|
251 | (1) |
|
15.8 Future Directions In Pharmacological Options for Adults Who Stutter |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (7) |
|
|
254 | (5) |
|
Section VI Related Fluency Disorders |
|
|
|
16 Cluttering: Etiology, Symptomatology, Identification, and Treatment |
|
|
259 | (12) |
|
|
|
|
|
259 | (1) |
|
16.1.1 Common Characteristics of Cluttering: Past and Present |
|
|
259 | (1) |
|
16.2 Diagnostic Considerations |
|
|
260 | (4) |
|
16.2.1 Important Background Information |
|
|
260 | (1) |
|
16.2.2 Continuous or Intermittent Rapid or Irregular Speech Rate |
|
|
261 | (1) |
|
16.2.3 Excessive "Normal" Disfluencies |
|
|
261 | (1) |
|
16.2.4 Excessive Moments of Over-Coarticulation |
|
|
261 | (1) |
|
|
261 | (1) |
|
16.2.6 Co-occurring Symptoms/Disorders |
|
|
261 | (2) |
|
16.2.7 Patterns of LCD Symptoms |
|
|
263 | (1) |
|
16.3 Cluttering Research: Past and Present |
|
|
264 | (1) |
|
16.4 Treatment Options for Cluttering |
|
|
265 | (2) |
|
16.4.1 Treatment of LCD Symptoms |
|
|
265 | (1) |
|
16.4.2 Improving Self-Regulation |
|
|
266 | (1) |
|
16.4.3 Treatment of Concomitant Symptoms/Disorders |
|
|
266 | (1) |
|
16.4.4 Treatment of Affective and Cognitive Components of Cluttering |
|
|
267 | (1) |
|
16.4.5 Cluttering and the Working Alliance |
|
|
267 | (1) |
|
16.5 Future Directions In cluttering |
|
|
267 | (1) |
|
|
268 | (1) |
|
|
269 | (2) |
|
|
269 | (2) |
|
17 Acquired Stuttering: Etiology, Symptomatology, Identification, and Treatment |
|
|
271 | (13) |
|
|
|
|
271 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
271 | (3) |
|
17.2.1 Acquired Neurogenic Stuttering |
|
|
271 | (3) |
|
17.2.2 Acquired Functional Stuttering |
|
|
274 | (1) |
|
|
274 | (2) |
|
17.3.1 Acquired Neurogenic Stuttering |
|
|
274 | (1) |
|
17.3.2 Acquired Functional Stuttering |
|
|
275 | (1) |
|
17.4 Diagnostic Considerations |
|
|
276 | (3) |
|
17.4.1 General Considerations |
|
|
276 | (1) |
|
17.4.2 Assessment Protocol |
|
|
277 | (2) |
|
|
279 | (2) |
|
17.5.1 General Considerations |
|
|
279 | (1) |
|
17.5.2 Treatment Approaches |
|
|
280 | (1) |
|
|
281 | (2) |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
283 | (1) |
References |
|
284 | (3) |
Index |
|
287 | |